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ABSTRACT
Objective: The aim was to study of multiorgan dysfunction in patients with dengue and to correlate the severity and clinical outcome with different 
hematological parameters.
Methods: All suspected cases of dengue admitted to medicine department within 1 year were evaluated and classified as dengue fever (DF), dengue 
hemorrhagic fever (DHF), and dengue shock syndrome (DSS).
Results: Out of 150 cases, 108 cases were classified as DF, 31 cases as DHF and 11 cases as DSS. Liver involvement was seen in 97.33% of cases. Jaundice 
was observed in 10 cases (6.6%), abnormal aspartate transaminase in 146 (97.33%) cases, and abnormal alanine transaminase in 126 (84%) cases. 
Bleeding manifestations was reported in 61 patients (40.6%). The presence of gastrointestinal bleeding in 17 patients (11.3%) was related to severe 
disease. Thrombocytopenia was present in 25% of DF cases, and in all cases of DHF and DS. Among these, prothrombin time (PT) was prolonged in 
10 cases and activated partial thromboplastin time (aPTT) in 47 patients. Serum fibrinogen was low in 28.57% of patients. Multiorgan dysfunction 
was observed in the form of simultaneous hepatic and renal dysfunction in 3.33% of cases, hepatic and central nervous system dysfunction in 2.66% 
of cases, hepatic and cardiac dysfunction in 2% of cases, and all the organ system dysfunction in 0.67% of cases.
Conclusion: The extent of increase of liver enzymes, PT, aPTT and fall of serum fibrinogen, and degree of thrombocytopenia correlated with disease 
severity. Acute renal failure, encephalitis, and myocarditis are manifestations of severe form of dengue. Major organ involvement may occur in simple 
DF also.
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INTRODUCTION
Dengue is one of the major re-emerging viral infections. In recent 
years, dengue has become a major global public health concern [1]. 
Approximately, 2.5 billion people (40% of the world’s population), 
living mainly in urban areas of tropical and subtropical regions, are 
estimated to be at risk of acquiring dengue infection. The WHO 
estimates that 50-100 million infections occur yearly including 
500,000 dengue hemorrhagic fever (DHF) cases and 22,000 deaths, 
mostly among children. While dengue is endemic in more than 100 
countries, most cases are reported from South-East Asia and the 
western Pacific regions [2]. The South-East Asia Region has become 
hyperendemic with regular reporting of dengue cases since 2000. 
The maximum number of cases (355,525) and deaths (1982) were 
recorded during 2010. Since then, a declining trend is being reported 
[3]. First recorded case in India was in the year of 1812. Although 
several measures were taken to prevent and control it, recurrent 
outbreaks have been reported in India and it was observed that 
clinical manifestations during recent outbreaks are slightly different 
from the previous ones [4]. Odisha state in 2010, enrolled its name 
for the first time in the list of states showing mortality due to dengue 
infection, with the reporting of 25 cases and five deaths [5]. Maximum 
number of cases during 2014 have been reported from Odisha (5079). 
Maximum number of death due to dengue infection has been reported 
from Kerala, Madhyapradesh, and Odisha (9 in each state). Hence, 
the elucidation of the exact clinical profile is very much required for 
proper patient management and saving of life.
Considering the rampant outbreaks of dengue in India, particularly in 
this eastern zone and studying various literatures regarding the varied 
clinical manifestations of dengue patients in recent years, this study 
was designed to evaluate the clinical outcomes of dengue patients and 
their various hematological parameters and finally to correlate these 
with the severity.
METHODS
The study included 150 patients with dengue virus infection admitted 
to the department of Medicine, Sriram Chandra Bhanja Medical College, 
Cuttack within 1 year. Inclusion criteria was all suspected cases of 
dengue as defined under National Vector Borne Disease Control 
Programme (NVBDCP), Government of India, who were tested positive 
for enzyme-linked immunosorbent assay (ELISA) based nonstructural 
protein 1 (NS1) antigen and immunoglobulin M (IgM) capture ELISA 
(MAC ELISA). Various exclusion criteria include patients with malaria 
or known positive serology for viral hepatitis, patients with chronic 
liver diseases, diabetes mellitus with nephropathy or cardiomyopathy, 
chronic kidney disease, and collagen vascular diseases.
The Institute Ethics Committee was approached for the Ethical 
Clearance. An informed consent was obtained from all the participants 
before collecting the blood samples.
Patients were evaluated and classified using the case definitions 
recommended by the WHO (1997) under NVBDCP, Government of 
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India as dengue fever (DF), DHF, and dengue shock syndrome (DSS). 
Various laboratory investigations and systemic investigations were 
carried out in all patients. All statistical analysis was performed in SPSS 
software version 20. Fischer’s exact test and student’s unpaired t-test 
were performed for significance of difference of proportions and means 
between two groups, respectively. Mann–Whitney test was used for 
significance of difference in means for non-Gaussian data.
Observations
In our study, out of 150 cases, total number of males were 106 (71%), 
whereas females were 44 (29%) in our study. Male to female ratio was 
2.4:1. Out of 150 patients, 83 (55.33%) were positive for NS1 ELISA, 
50 (33.33%) positive for IgM ELISA, and 17 (11.33%) were positive 
for both. Fever was the main presenting symptom (100%) in all our 
patients followed by headache (94%), myalgia (90.6%), nausea/
vomiting (80%), retro-orbital pain (42%), bleeding manifestations 
(40.6%), rash (35.3%), arthralgia (26.6%), abdominal pain (23.3%), 
and diarrhea (14.6%). The clinical examination revealed jaundice in 
10 patients (6.6%). Ultrasonographic evaluation revealed hepatomegaly 
in 62 patients (41.3%). Prothrombin time (PT) and activated partial 
thromboplastin time (aPTT) were high in patients with bleeding 
manifestations and even higher in patients with gastrointestinal (GI) 
hemorrhage. Non survivors showed PT, aPTT of more than 1 minute. 
aPTT was significantly abnormal in more percentage of patients with 
bleeding manifestations and GI hemorrhage than PT. Serum fibrinogen 
was low in 28.57% of patients with bleeding manifestations, 50% of 
those with GI hemorrhage and all patients of nonsurvivors.
Out of 150 cases, acute renal failure (ARF) was present in 4% (n=6) 
of cases, Proteinuria in 22% (n=33) cases and hematuria in 4% (n=6) 
cases. Renal Complications are more manifested in severe dengue 
(DHF and DSS). Out of 6 patients of dengue with ARF, 2 patients died 
with multiorgan dysfunction. One patient had ARF, proteinuria and 
hematuria. Another had both ARF and proteinuria. Both the patients 
had Jaundice, prolonged PT, aPTT with low serum fibrinogen. Out of the 
two, one had dengue encephalitis.
Out of all the dengue patients, 3 patients with severe dengue had 
following features arrhythmia, myocarditis, hypotension, and 
pulmonary edema. Out of the 3 patients, one had DHF and two had 
DSS. All the 3 patients had abnormal electrocardiogram reading. Two 
patients had atrial fibrillation and one patient had features of 1st degree 
heart block. Myocarditis was present in 33.3% of patients, hypotension 
in 66.67% of patients and pulmonary edema in 66.67% of patients in 
severe dengue, presenting with cardiovascular manifestations. Two-
dimensional echocardiographic evaluation was done in all 3 patients. 
2 patients had normal Echo study and one had features of myocarditis. 
A fatal outcome was reported in a case with DSS with myocarditis.
Out of 150 dengue patients, only 5 patients (3.33%) presented with 
dengue encephalitis. Most of the patients (n=4) belonged to severe 
form of dengue (DHH and DSS). Apart from fever and headache, altered 
sensorium (60%) and convulsion (40%), remain the most common 
presentation of dengue encephalitis (n=5). Cerebral edema has been 
primary finding in computed tomography scan and magnetic resonance 
imaging (MRI). MRI revealed cerebral edema in (3/5) majority of patients.
DISCUSSION
This prospective study was conducted to assess multiorgan dysfunction 
in dengue and the association of clinical outcomes and different 
hematological parameters with the severity of 150 serologically 
confirmed cases of dengue infection during 1 year in the Department of 
Medicine, SCB Medical College, and Cuttack.
Males were predominantly infected in each age group. The male 
predominance has also been reported in several other studies [6]. The 
mean age of patients in our study was 32.4 years which is similar to 
other studies where higher age groups were observed of developing 
symptomatic disease than younger groups [7-9] and contradictory to 
the study by Raut and Patil where they revealed children <10 years 
were affected more [10].
In our study, 72% of patients were classified as DF, 21% as DHF and 7% 
as DSS. A very similar study from eastern India by Chatterjee et al. on 
180 serologically confirmed dengue cases showed an incidence of 71% 
and 29% of DF and DHF/DSS cases respectively [11]. Chhina et al. [12] 
and Makroo et al. [13] reported 19% of cases of DHF/DSS cases.
Fever was the main presenting symptom in all our patients followed 
by headache (94%), myalgia (90.6%). Sedhain et al. in their study of 
414 patients with dengue infection in Nepal reported a profile of clinical 
manifestations akin to our cases [14]. Abdominal pain in our study 
was present in 35/150 (23.3%) cases. This is in agreement with the 
study of Chhina et al. who similarly reported pain abdomen in 20% of 
cases [12]. Our study showed hepatomegaly in 41.3% of cases. Recent 
studies suggest that hepatomegaly is present at between 50 and 100% 
of cases [15] while some have documented lower rate of hepatomegaly 
like 24% by Itha et al. [16].
Bleeding in dengue is due to thrombopathy, coagulopathy, and 
vasculopathy. Bleeding manifestations in our study was reported in 
40.6% of cases. Bleeding into different sites has been observed in most 
studies [17-19].
Thrombocytopenia (total platelet count [TPC] <100,000/cm2) was 
present in 25% of DF cases, whereas in all cases of DHF and DSS. 
None had GI hemorrhage. Sedhain et al. also reported a platelet 
count of <50,000/cm2 in 9.73% of DF patients, which was similar to 
our finding [14]. Thrombocytopenia is a major finding in a significant 
number of cases of DHF/DSS and increases with severity of disease.
In our study, Table 1 showed abnormal aspartate transaminase (AST) 
was present in 96.29% of DF cases and in all patients with DHF and 
DSS in our study. Similarly, abnormal alanine transaminase (ALT) was 
present in 79.62% of DF cases, 93.54% of DHF cases and in all patients 
of DSS. Total bilirubin, AST, ALT, alkaline phosphatase (ALP) were 
significantly higher in DHF and DSS groups than DF category. The AST 
levels in dengue infection tend to be greater than ALT levels. This differs 
from the pattern in viral hepatitis but is similar to that seen in alcoholic 
hepatitis. The exact cause of this difference is unknown, but it has been 
suggested that it may be due to excess release of AST from damaged 
monocytes during dengue infection [20]. Ageep in 2012 reported 
high AST and ALT levels in 86% and 82% of patients, respectively 
[21]. However, Wong and Shen reported that AST abnormality was 
predominantly higher than ALT, 91% and 72%, respectively [22].
Serum albumin was significantly lower in severe dengue infections 
(DHF/DSS) than patients with DF. Hypoalbuminaemia is a result of 
impairment of the synthetic function of liver as it is the target organ of 
dengue virus. Hypoalbuminemia is more severe in severe dengue [23].
In Saudi Arabia, Khan et al. found an association between high AST 
level and complications in dengue infection [24]. A report from India by 
Shah pointed to a high mortality in dengue patients with hepatitis and 
encephalopathy [25]. Ageep noticed relation between the degree of liver 
damage and the presence of complications [21]. In 71% of the patients 
having DHF, severe degree of liver damage was observed. He suggested that 
the deranged liver functions may participate in the causation of bleeding 
in these patients. Severe degree of liver injury also was found in 80% of 
DSS. All of the patients having encephalopathy had severe liver damage. 
He proposed encephalopathy may be due to fulminant hepatic failure or 
a high level of the virus that directly damage the brain. Involvement of the 
kidneys was also related to the severity of liver damage.
According to Table 2, PT, aPTT were high in our patients with bleeding 
manifestations and even higher in patients with GI hemorrhage. Non 
survivors showed PT, aPTT of more than 1 minute. This observation is 
similar to earlier studies by Hathirat et al. that aPTT is more frequently 
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abnormal than PT suggesting that a defect occurs in the intrinsic 
pathway of coagulation [26]. An analysis of the linear correlation and 
regression between the levels of AST/ALT and aPTT show a strong 
association between AST/ALT elevation and aPTT prolongation in 
DHF and DSS patients. This suggests dysfunction of the damaged liver 
might be responsible for the decreased synthesis of specific factors in 
the intrinsic pathway. Increased factor consumption as indicated by 
high level of tissue plasminogen activator in previous studies is also 
associated with aPTT prolongation, but in a less significant manner. Low 
serum fibrinogen level of our study is in agreement with various other 
studies [27].
Table 3 reported GI hemorrhage was a consistent finding in our patients 
with severe dengue. This correlated with higher bilirubin, AST, ALT, ALP, 
prolonged PT, aPTT, low TPC, low albumin, and low fibrinogen.
In our study of 150 patients (Table 4), 5 cases of ARF had severe dengue 
(DHF and DSS), but one case of ARF was detected in the absence of 
hemorrhage or shock. Out of 33 (22%) patients with proteinuria, 
29 (87.87%) patients had severe dengue. All of the patients (n=6) 
(4%) with hematuria had severe dengue. 12.9% of DHF patients had 
hematuria. The study by Horvath et al. also showed proteinuria in 74% 
of patients with severe dengue and hematuria in 12.5% of patients 
with DHF [28]. The study by Nair et al. in 2012 presented a patient 
with DF with ARF requiring hemodialysis in the absence of features of 
hemorrhage or shock, as seen in one case in our study [29].
In our study, 3 patients with severe dengue had cardiological 
manifestations. Out of which, one had DHF and two had DSS. 
A fatal outcome was reported in a case as DSS with myocarditis and 
encephalitis. The patient died from multiorgan dysfunction.
Table 1: Comparison of laboratory parameters among patients with DF, DHF and DSS
Laboratory category variables DF (n=108) DHF (n=31) p¥ value DSS (n=11) p¥¥ value
PCV* 38.32±0.46 33.13±0.85 <0.001 35±3.02 0.055
TPC* 1.42±0.06 0.59±0.03 <0.001 0.53±0.08 <0.001
Total bilirubin* 1±0.04 1.87±0.34 <0.001 2.89±0.59 <0.001
AST* 151.5±17.56 316.7±9.68 <0.001 509.7±0.69 <0.001
ALT* 110.3±16.09 182.2±4.67 <0.001 397.5±67.3 <0.001
ALP* 161.8±7.07 205.1±0.11 0.024 211±34.86 0.526
Sr. Albumin* 3.42±0.03 3.15±0.03 <0.001 2.53±0.11 <0.001
*Data are expressed as the mean±SEM. ¥p value between DF and DHF groups. ¥¥p value between DF and DSS groups. DF: Dengue fever, DHF: Dengue hemorrhagic fever, 
DSS: Dengue shock syndrome, PCV: Packed cell volume, TPC: Total platelet count
Table 2: Comparison of coagulation and hematological parameters in patients with DF, DHF, and DSS
Parameters DF (n=108) (%) DHF (n=31) (%) p# value DSS n=11 (%) p## value
PT (n=61)* Number (%) of patients with>ULN 0/19 (0) 4/31 (12.9) 0.283 6/11 (54.5) <0.001
aPTT (n=61)* Number (%) of patients with>ULN 6/19 (31.6) 30/31 (96.8) <0.001 11/11 (100) <0.001
Sr. Fibrinogen (n=42)* Number (%) of patients with<LLN 0/7 (0) 5/25 (20) 0.560 7/10 (70) 0.009
TPC<50,000 6/108 (5.5) 12/31 (38.7) <0.001 6/11 (54.5) <0.001
PCV≥20 0/108 (0) 5/31 (16.1) <0.001 6/11 (54.5) <0.001
*Number of patients in which the test was available. #p value between DF and DHF groups. ##p value between DF and DSS groups. ULN: Upper limit of normal, 
LLN: Lower limit of normal. (Normal upper limit of PT-16.7 seconds and for aPTT-34.6 seconds. Normal serum fibrinogen-1.1-4.2 g/L). DF: Dengue fever, DHF: Dengue 
hemorrhagic fever, DSS: Dengue shock syndrome, PCV: Packed cell volume, TPC: Total platelet count
Table 3: Comparison of clinical parameters among patients with dengue infection
Clinical category variables DF n=108 (%) DHF n=31 (%) p¥ value DSS n=11 (%) p¥¥ value
Rash (%) 47/108 (43.5) 4/31 (12.9) 0.001 2/11 (18.2) 0.121
Muco-cutaneous bleeding (%) 19/108 (17.6) 29/31 (93.5) <0.001 10/11 (90.9) <0.001
GI hemorrhage (%) 0/108 (0) 12/31 (38.7) <0.001 5/11 (45.4) <0.001
Jaundice (%) 2/108 (1.9) 4/31 (12.9) 0.022 4/11 (36.4) <0.001
ARF (%) 1/108 (0.925) 2/31 (6.451) <0.001 3/11 (27.27) <0.001
Hematuria 0 (0) 4/31 (12.95) <0.002 2/11 (18.19) <0.001
Proteinuria 4/108 (3.7) 20/31 (64.5) <0.001 9/11 (81.81) <0.001
Arrhythmia 0 (0) 1/31 (3.22) <0.001 2/11 (18.18) <0.001
Myocarditis 0 (0) 0 (0) <0.001 1/11 (9.09) <0.001
Encephalopathy 1 (0.925) 2 (6.5) <0.001 2 (18.18) <0.001
*Data are expressed as the mean±SEM. ¥p value between DF and DHF groups. ¥¥p value between DF and DSS groups. DF: Dengue fever, DHF: Dengue hemorrhagic fever, 
GI: Gastrointestinal, ARF: Acute renal failure
Table 4: Comparison of renal complications and cardiac complications in DF, DHF, and DSS cases
Comparison of renal complications Comparison of cardiac complications
Clinical category DF n=108 (%) DHF (n=31) (%) DSS (n=11) (%) Clinical category (n=3) DF (n=0) DHF (n=1) DSS (n=2)
ARF (n=6) 1 (0.925) 2 (6.45) 3 (27.23) Arrhythmia 0 1 2
Proteinuria (n=33) 4 (3.70) 20 (64.5) 9 (81.81) Myocarditis 0 0 1
Hematuria (n=6) 0 (0) 4 (12.9) 2 (18.19) Hypotension 0 0 2
Pulmonary edema 0 1 1
DF: Dengue fever, DHF: Dengue hemorrhagic fever, ARF: Acute renal failure
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Five patients developed neurological manifestation in the form of 
altered sensorium (n=3) and convulsion (n=2). Overall, 4 cases of 
encephalitis had severe dengue (80%), but one case was detected in 
DF, in the absence of hemorrhage or shock. The study by Puccioni-
Sohler et al., showed neurological involvement in 4.5% of confirmed 
dengue cases [30]. MRI revealed cerebral edema in patients with 
dengue encephalitis. The study by Cam et al., showed, out of 18 patients 
with dengue encephalitis, 12 (66%) had cerebral edema, no change in 
4 patients, and only the minority (n=2) showed specifically scattered 
focal lesions in MRI [31]. The study by Solomon et al. showed dengue 
presenting as acute encephalitic syndrome without manifestation of the 
disease, which we found in one case in our study [32]. The two patients 
with encephalopathy, one each belonged to DHF and DSS group, died 
due to multiorgan dysfunction.
Limitations of our study mainly include leaving out all outpatient 
departmental cases. Relevant data were collected only from the admitted 
patients. Furthermore, there was lacking of entomological data.
CONCLUSION
This may be concluded from our study that, the extent of rise of liver 
enzymes, PT, aPTT, the extent of fall of serum fibrinogen, and the 
degree of thrombocytopenia, correlated with disease severity. ARF, 
encephalitis and myocarditis are manifestations of severe form of 
dengue with poor clinical outcome. Major organ involvement may occur 
in simple DF also. This study will be helpful for the clinicians to have 
a better understanding regarding clinical manifestations, outcomes, 
and complications of dengue infection. Although some known clinical 
features are still manifesting, but various atypical features have 
also reported in different epidemics. Hence always a continuous and 
timely sero-epidemiological surveillance is required in endemic areas 
of dengue with proper interventions to minimize its complications, 
outbreak, and mortality.
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